| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |